Logo image of VERO

VENUS CONCEPT INC (VERO) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:VERO - US92332W3034 - Common Stock

1.78 USD
+0.02 (+1.14%)
Last: 11/21/2025, 8:04:27 PM
1.81 USD
+0.03 (+1.69%)
After Hours: 11/21/2025, 8:04:27 PM

VERO Key Statistics, Chart & Performance

Key Statistics
Market Cap3.31M
Revenue(TTM)64.83M
Net Income(TTM)-41.34M
Shares1.86M
Float1.83M
52 Week High14.5
52 Week Low1.65
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-48.84
PEN/A
Fwd PEN/A
Earnings (Next)03-30 2026-03-30/amc
IPO2017-10-12
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment


VERO short term performance overview.The bars show the price performance of VERO in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -5 -10 -15 -20 -25

VERO long term performance overview.The bars show the price performance of VERO in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of VERO is 1.78 USD. In the past month the price decreased by -20.18%. In the past year, price decreased by -50.21%.

VENUS CONCEPT INC / VERO Daily stock chart

VERO Latest News, Press Relases and Analysis

VERO Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 25.67 222.97B
ISRG INTUITIVE SURGICAL INC 65.23 201.33B
BSX BOSTON SCIENTIFIC CORP 32.84 143.55B
SYK STRYKER CORP 27.96 140.79B
IDXX IDEXX LABORATORIES INC 57.57 58.07B
BDX BECTON DICKINSON AND CO 13.36 55.24B
EW EDWARDS LIFESCIENCES CORP 33.12 49.40B
RMD RESMED INC 25.33 36.59B
GEHC GE HEALTHCARE TECHNOLOGY 16.66 34.82B
DXCM DEXCOM INC 32.38 23.62B
PODD INSULET CORP 72.47 23.30B
ZBH ZIMMER BIOMET HOLDINGS INC 11.39 18.26B

About VERO

Company Profile

VERO logo image Venus Concept, Inc. is a global medical technology company, which engages in the business of developing, commercializing, and selling minimally invasive and non-invasive medical aesthetic and hair restoration technologies. The company is headquartered in Toronto, Ontario and currently employs 292 full-time employees. The company went IPO on 2017-10-12. The firm develops, commercializes and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services and reaches over 60 countries and nine direct markets. The Company’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Versa Pro, Venus Legacy, Venus Velocity, Venus Viva, Venus Glow, Venus Bliss, Venus Bliss MAX, Venus Epileve, Venus Viva MD and AI.ME. Its treatments for hair loss are divided into non-surgical options and surgical procedures. Its hair restoration systems include NeoGraft and the ARTAS iX Robotic Hair Restoration system. Its systems are designed on flexible platforms that enable it to expand beyond the aesthetic industry’s traditional markets of dermatology and plastic surgery, and into non-traditional markets, including family medicine and general practitioners and aesthetic medical spas.

Company Info

VENUS CONCEPT INC

235 Yorkland Blvd Suite 900

TORONTO ONTARIO M2J 4Y8 CA

CEO: Domenic Serafino

Employees: 292

VERO Company Website

VERO Investor Relations

Phone: 18778488430

VENUS CONCEPT INC / VERO FAQ

What does VENUS CONCEPT INC do?

Venus Concept, Inc. is a global medical technology company, which engages in the business of developing, commercializing, and selling minimally invasive and non-invasive medical aesthetic and hair restoration technologies. The company is headquartered in Toronto, Ontario and currently employs 292 full-time employees. The company went IPO on 2017-10-12. The firm develops, commercializes and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services and reaches over 60 countries and nine direct markets. The Company’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Versa Pro, Venus Legacy, Venus Velocity, Venus Viva, Venus Glow, Venus Bliss, Venus Bliss MAX, Venus Epileve, Venus Viva MD and AI.ME. Its treatments for hair loss are divided into non-surgical options and surgical procedures. Its hair restoration systems include NeoGraft and the ARTAS iX Robotic Hair Restoration system. Its systems are designed on flexible platforms that enable it to expand beyond the aesthetic industry’s traditional markets of dermatology and plastic surgery, and into non-traditional markets, including family medicine and general practitioners and aesthetic medical spas.


What is the current price of VERO stock?

The current stock price of VERO is 1.78 USD. The price increased by 1.14% in the last trading session.


What is the dividend status of VENUS CONCEPT INC?

VERO does not pay a dividend.


What is the ChartMill technical and fundamental rating of VERO stock?

VERO has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


On which exchange is VERO stock listed?

VERO stock is listed on the Nasdaq exchange.


Can you provide the sector and industry classification for VENUS CONCEPT INC?

VENUS CONCEPT INC (VERO) operates in the Health Care sector and the Health Care Equipment & Supplies industry.


What is the market capitalization of VERO stock?

VENUS CONCEPT INC (VERO) has a market capitalization of 3.31M USD. This makes VERO a Nano Cap stock.


VERO Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

VERO Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to VERO. VERO has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

VERO Financial Highlights

Over the last trailing twelve months VERO reported a non-GAAP Earnings per Share(EPS) of -48.84. The EPS increased by 44.64% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -65.52%
ROE -1776.32%
Debt/Equity 6.82
Chartmill High Growth Momentum
EPS Q2Q%13.78%
Sales Q2Q%-8.2%
EPS 1Y (TTM)44.64%
Revenue 1Y (TTM)-15.09%

VERO Forecast & Estimates

For the next year, analysts expect an EPS growth of 76.72% and a revenue growth -9.41% for VERO


Analysts
Analysts45.71
Price TargetN/A
EPS Next Y76.72%
Revenue Next Year-9.41%

VERO Ownership

Ownership
Inst Owners13.23%
Ins Owners0.78%
Short Float %5.21%
Short Ratio0.12